Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices

The spending by the industry’s main trade group and seven key drugmakers has climbed to a level not seen in a decade.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.